Menu
Currency
GWAS Study

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

Rongve A, Witoelar A, Ruiz A et al.

31065058 PubMed ID
GWAS Study Type
82963 Participants
49 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RA
Rongve A
WA
Witoelar A
RA
Ruiz A
AL
Athanasiu L
AC
Abdelnour C
CJ
Clarimon J
HS
Heilmann-Heimbach S
HI
Hernández I
MS
Moreno-Grau S
DR
de Rojas I
ME
Morenas-Rodríguez E
FT
Fladby T
SS
Sando SB
BG
Bråthen G
BF
Blanc F
BO
Bousiges O
LA
Lemstra AW
VS
van Steenoven I
LE
Londos E
AI
Almdahl IS
PL
Pålhaugen L
EJ
Eriksen JA
DS
Djurovic S
SE
Stordal E
SI
Saltvedt I
UI
Ulstein ID
BF
Bettella F
DR
Desikan RS
IA
Idland AV
TM
Toft M
PL
Pihlstrøm L
SJ
Snaedal J
TL
Tárraga L
BM
Boada M
LA
Lleó A
SH
Stefánsson H
SK
Stefánsson K
RA
Ramírez A
AD
Aarsland D
AO
Andreassen OA
Chapter II

Abstract

Summary of the research findings

Dementia with Lewy Bodies (DLB) is a common neurodegenerative disorder with poor prognosis and mainly unknown pathophysiology. Heritability estimates exceed 30% but few genetic risk variants have been identified. Here we investigated common genetic variants associated with DLB in a large European multisite sample. We performed a genome wide association study in Norwegian and European cohorts of 720 DLB cases and 6490 controls and included 19 top-associated single-nucleotide polymorphisms in an additional cohort of 108 DLB cases and 75545 controls from Iceland. Overall the study included 828 DLB cases and 82035 controls. Variants in the ASH1L/GBA (Chr1q22) and APOE ε4 (Chr19) loci were associated with DLB surpassing the genome-wide significance threshold (p < 5 × 10-8). One additional genetic locus previously linked to psychosis in Alzheimer's disease, ZFPM1 (Chr16q24.2), showed suggestive association with DLB at p-value < 1 × 10-6. We report two susceptibility loci for DLB at genome-wide significance, providing insight into etiological factors. These findings highlight the complex relationship between the genetic architecture of DLB and other neurodegenerative disorders.

720 European ancestry cases, 6,490 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

82963
Total Participants
GWAS
Study Type
Yes
Replicated
108 European ancestry cases, 75,545 European ancestry controls
Replication Participants
European
Ancestry
Iceland, France, Netherlands, Norway, Sweden, Spain
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.